56 phenotypes from multigenic genotypes

Allelic Composition Genetic Background	Annotated Term	Reference
Chuktm1Mka/Chuk+ SfnEr/SfnEr involves: 129S1/Sv * 129X1/SvJ	normal craniofacial phenotype	J:184926
Chuktm1Mka/Chuk+ Irf6tm1Mjd/Irf6tm1Mjd involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal incisor morphology	J:184926
Chuktm1Mka/Chuktm1Mka Irf6tm1Mjd/Irf6+ involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal incisor morphology	J:184926
Chuktm1Mpa/Chuktm1Mpa Ikbkbtm2Cgn/Ikbkbtm2Cgn Tg(Alb1-cre)7Gsc/0 involves: C57BL/6 * FVB/N	abnormal bile canaliculus morphology	J:137861
	abnormal bile duct morphology	J:137861
	cachexia	J:137861
	decreased survivor rate	J:137861
	increased circulating alanine transaminase level	J:137861
	increased circulating bilirubin level	J:137861
	increased susceptibility to endotoxin shock	J:137861
	intrahepatic cholestasis	J:137861
	jaundice	J:137861
	postnatal growth retardation	J:137861
	premature death	J:137861
Chuktm1Ver/Chuktm1Ver Ikbkbtm1Ver/Ikbkbtm1Ver involves: 129S4/SvJae * C57BL/6J	abnormal cell physiology	J:63443
	abnormal dorsal root ganglion morphology	J:63443
	abnormal hindbrain morphology	J:63443
	abnormal neural fold elevation formation	J:63443
	embryonic lethality during organogenesis, complete penetrance	J:63443
	increased embryonic neuroepithelium apoptosis	J:63443
	increased hepatocyte apoptosis	J:63443
	increased hindbrain apoptosis	J:63443
	increased spinal cord apoptosis	J:63443
	liver degeneration	J:63443
	open neural tube	J:63443
	small embryonic telencephalon	J:63443
Chuktm1Ver/Chuktm1Ver Ikbkbtm1Ver/Ikbkbtm1Ver Tnfrsf1atm1Mak/Tnfrsf1atm1Mak involves: 129/Sv * 129S4/SvJae * C57BL/6J	broad limb buds	J:63443
	curly tail	J:63443
	lethality throughout fetal growth and development, complete penetrance	J:63443
	open neural tube	J:63443
Chuktm1Ver/Chuktm1Ver Tnfrsf1atm1Mak/Tnfrsf1atm1Mak involves: 129/Sv * 129S4/SvJae * C57BL/6J	broad limb buds	J:63443
	curly tail	J:63443
Chuktm1Yhu/Chuktm1Yhu Egfrtm1Mag/Egfr+ Tg(KRT5-cre)5132Jlj/0 involves: 129 * C57BL/6 * CD-1	abnormal coat/ hair morphology	J:141162
	abnormal eye morphology	J:141162
	decreased survivor rate	J:141162
	premature death	J:141162
	thick epidermis	J:141162
Chuktm1Yhu/Chuktm1Yhu Egfrtm1Mag/Egfrtm1Mag Tg(KRT5-cre)5132Jlj/0 involves: 129 * C57BL/6 * CD-1	postnatal lethality, complete penetrance	J:141162
Chuktm1Yhu/Chuktm1Yhu Egfrwa2/Egfrwa2 Tg(KRT5-cre)5132Jlj/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6	abnormal epidermal layer morphology	J:141162
	normal integument phenotype	J:141162
	premature death	J:141162
Chuktm1Yhu/Chuktm1Yhu Tnfrsf1atm1Mak/Tnfrsf1atm1Mak Tg(KRT5-cre)5132Jlj/0 involves: 129S1/Sv * 129S2/SvPas * 129X1/SvJ * C57BL/6	epidermal hyperplasia	J:141162
	postnatal lethality	J:141162
	thick epidermis	J:141162
Chuktm2Mka/Chuktm2Mka Tg(MMTV-CCND1)1Esmp/? Not Specified	normal endocrine/exocrine gland phenotype	J:90978
Chuktm2Mka/Chuktm2Mka Tg(Tnfsf13b)1Fma/? B6.Cg-Chuktm2Mka Tg(Tnfsf13b)1Fma	abnormal B cell activation	J:113556
	absent spleen marginal zone	J:113556
	decreased marginal zone B cell number	J:113556
	increased anti-double stranded DNA antibody level	J:113556
	increased transitional stage B cell number	J:113556
	increased urine protein level	J:113556
Chuktm2Yhu/Chuktm2Yhu Tg(KRT5-CHUK)#Yhu/0 involves: 129S1/Sv * 129X1/SvJ * FVB/N	normal mortality/aging	J:197037
	normal neoplasm	J:197037
Chuktm2Yhu/Chuktm2Yhu Tg(Lor-CHUK)8Yhu/0 involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N	increased CD4-positive, alpha-beta T cell number	J:197037
	increased CD8-positive, alpha-beta T cell number	J:197037
	increased macrophage cell number	J:197037
	increased neutrophil cell number	J:197037
	increased squamous cell carcinoma incidence	J:197037
	lung inflammation	J:197037
	stomach mucosa hyperplasia	J:197037
Chuktm2Yhu/Chuktm2Yhu Tg(Lor-CHUK)8Yhu/0 involves: 129S1/Sv * 129X1/SvJ * FVB/N	absent lymph nodes	J:197037
	enlarged lung	J:197037
	increased lung squamous cell carcinoma incidence	J:197037
	increased lung tumor incidence	J:197037
	normal integument phenotype	J:197037
	premature death	J:197037